ECMOHO Limited is an internet retail business based in the US. ECMOHO shares (MOHO) are listed on the NASDAQ and all prices are listed in US Dollars. ECMOHO employs 455 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Guided investing
Our top pick for
Building a portfolio
Our top pick for
Beginners
| Latest market close | $0.35 |
|---|---|
| 52-week range | $0.35 - $3.23 |
| 50-day moving average | $0.48 |
| 200-day moving average | $1.01 |
| Wall St. target price | $5.00 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-0.40 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $0.346 from 2022-01-19
| 1 week (2022-01-13) | -4.42% |
|---|---|
| 1 month (2021-12-20) | -17.62% |
| 3 months (2021-10-20) | -40.55% |
| 6 months (2021-07-20) | -74.18% |
| 1 year (2021-01-20) | -84.89% |
|---|---|
| 2 years (2020-01-17) | -95.16% |
| 3 years (2019-01-16) | N/A |
| 5 years (2017-01-16) | N/A |
Valuing ECMOHO stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of ECMOHO's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
ECMOHO's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $5.6 million.
The EBITDA is a measure of a ECMOHO's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $170 million |
|---|---|
| Gross profit TTM | $58.6 million |
| Return on assets TTM | -5.92% |
| Return on equity TTM | -18.07% |
| Profit margin | -8.11% |
| Book value | $1.80 |
| Market capitalisation | $16.5 million |
TTM: trailing 12 months
We're not expecting ECMOHO to pay a dividend over the next 12 months.
Over the last 12 months, ECMOHO's shares have ranged in value from as little as $0.35 up to $3.23. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while ECMOHO's is 0.9925. This would suggest that ECMOHO's shares are less volatile than average (for this exchange).
ECMOHO Limited, an investment holding company, operates as an integrated solution provider in the non-medical health and wellness market. The company offers health supplements and food, mother and child care products, personal care products, and household healthcare equipment and cleaning products. It also operates an online e-commerce platform. The company is also involved in the provision of bonded area warehousing; online store operating services; and promotion and marketing services to its brand partners and other brand customers. It serves consumers and retailers. The company was founded in 2011 and is headquartered in Shanghai, the People's Republic of China. .
Car-sharing service Turo has filed plans for an IPO. What you need to know.
Monie offers 5% APY on deposits, but funds aren’t insured and the interface is buggy.
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Buffett’s Berkshire Hathaway may now be on its way to becoming the next trillion-dollar company.
Record vehicle deliveries cause the Tesla stock price to move close to all-time highs.
Everything we know about the Affinia Therapeutics IPO, plus information on how to buy in.
Everything we know about the Austin Gold IPO, plus information on how to buy in.
Everything we know about the VinFast IPO, plus information on how to buy in.
Everything we know about the Nexalin Technology IPO, plus information on how to buy in.
Everything we know about the Specialty Building Products IPO, plus information on how to buy in.